USA - New York Stock Exchange - NYSE:QGEN - NL0015002CX3 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.07B | 1.98B | 1.97B | 2.14B | 2.25B | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 743.33M | 715.81M | 731.62M | 756.96M | 800.84M | |||
| Gross Profit | 1.33B | 1.26B | 1.23B | 1.38B | 1.45B | |||
| Operating Expenses | 767.92M | 767.45M | 788.44M | 808.34M | 792.97M | |||
| Research and Development | 188.89M | 193.49M | 198.51M | 189.86M | 189.96M | |||
| Selling, General, and Administrative Expenses | 571.50M | 564.36M | 579.17M | 603.95M | 584.47M | |||
| Operating Income | 559.52M | 494.96M | 445.25M | 576.23M | 657.85M | |||
| Interest Income/Expense | 19.25M | 23.48M | 23.98M | -19.10M | -5.12M | |||
| Other Income/Expense | 4.69M | -39.00K | 89.00K | 241.00K | 871.00K | |||
| Non Recurring Items | -76.52M | -397.25M | -39.51M | -44.77M | -27.76M | |||
| Income Before Taxes | 506.95M | 121.15M | 429.81M | 512.60M | 625.83M | |||
| Income Tax | 101.58M | 37.56M | 88.51M | 89.39M | 113.23M | |||
| Net Income | 405.37M | 83.59M | 341.30M | 423.21M | 512.60M | |||
| EBITDA | 749.43M | 698.23M | 650.58M | 784.63M | 872.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.84 | 0.38 | 1.53 | 1.90 | 2.28 | |||
| Non GAAP EPS | 2.37 | 2.22 | 2.12 | 2.44 | 2.73 | |||
| Statistics | ||||||||
| Gross Profit Margin | 64.10% | 63.82% | 62.77% | 64.65% | 64.43% | |||
| Profit Margin | 19.58% | 4.23% | 17.37% | 19.76% | 22.77% | |||
| Operating Profit Margin | 27.02% | 25.02% | 22.66% | 26.91% | 29.22% | |||
All data in USD